KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E Adjustments
Ratios

TherapeuticsMD (TXMD) Shares Outstanding (2021 - 2024)

Historic Shares Outstanding for TherapeuticsMD (TXMD) over the last 4 years, with Q2 2024 value amounting to $11.5 million.

  • TherapeuticsMD's Shares Outstanding rose 904.96% to $11.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $11.5 million, marking a year-over-year increase of 904.96%. This contributed to the annual value of $11.5 million for FY2023, which is 2141.5% up from last year.
  • TherapeuticsMD's Shares Outstanding amounted to $11.5 million in Q2 2024, which was up 904.96% from $11.5 million recorded in Q1 2024.
  • TherapeuticsMD's 5-year Shares Outstanding high stood at $11.5 million for Q4 2023, and its period low was $8.6 million during Q4 2021.
  • Its 4-year average for Shares Outstanding is $10.5 million, with a median of $10.6 million in 2023.
  • As far as peak fluctuations go, TherapeuticsMD's Shares Outstanding surged by 2141.5% in 2023, and later soared by 904.96% in 2024.
  • Over the past 4 years, TherapeuticsMD's Shares Outstanding (Quarter) stood at $8.6 million in 2021, then grew by 10.48% to $9.5 million in 2022, then increased by 21.42% to $11.5 million in 2023, then changed by 0.0% to $11.5 million in 2024.
  • Its Shares Outstanding stands at $11.5 million for Q2 2024, versus $11.5 million for Q1 2024 and $11.5 million for Q4 2023.